ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,261 | -13.0% | 60,514 | 0.0% | 0.01% | -20.0% |
| Q2 2023 | $1,449 | +27.2% | 60,514 | 0.0% | 0.01% | +25.0% |
| Q1 2023 | $1,139 | +12.8% | 60,514 | -4.7% | 0.01% | 0.0% |
| Q4 2022 | $1,010 | -99.9% | 63,470 | -5.5% | 0.01% | 0.0% |
| Q3 2022 | $1,099,000 | +16.2% | 67,147 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $946,000 | -41.8% | 67,147 | 0.0% | 0.01% | -30.0% |
| Q1 2022 | $1,626,000 | +45.6% | 67,147 | +41.5% | 0.01% | +66.7% |
| Q4 2021 | $1,117,000 | -25.9% | 47,457 | -47.7% | 0.01% | -25.0% |
| Q3 2021 | $1,507,000 | -61.0% | 90,757 | -42.7% | 0.01% | -66.7% |
| Q2 2021 | $3,862,000 | +310.0% | 158,357 | +333.6% | 0.02% | +300.0% |
| Q1 2021 | $942,000 | -0.8% | 36,522 | +86.3% | 0.01% | -25.0% |
| Q2 2020 | $950,000 | – | 19,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |